REGENXBIO Inc.
REGENXBIO Inc.
RGNX
Valuace
70
Růst
8
Zdraví
75
Cena
$ 10.95
Dnes
--0.14 (-1.02%)
Souhrn
Výkazy
Ukazatele
Profil
Držitelé
Návštěvnost webu
Konkurence
Zprávy společnosti
Kapitalizace
0.6B
Obrat
0B
Zisk
0B
Aktiva
1B
Dluh
0B
ROE
-110%
ROA
-34%
PE
-2
PS
2
Cena 1R
5-16
⌀ Cena
10.17
Dividenda
0.0(0.0%)
Čtvrtletní 10-Q
10-Q
Celoroční 10-K
8-K
Nadcházející oznámení zisků
12-03-2026
Poslední dividenda

Profil

REGENXBIO Inc., biotechnologická společnost v klinickém stadiu, poskytuje kandidáty na genovou terapii pro genovou terapii, která dodává geny buňkám k řešení genetických vad nebo umožňuje buňkám v těle produkovat terapeutické proteiny nebo protilátky, které jsou určeny k ovlivnění onemocnění. Jeho kandidáty na genovou terapii jsou založeny na NAV Technology Platform, proprietární adeno-asociované platformě pro poskytování genů. Hlavní kandidátskou látkou společnosti je RGX- 314, který je v klinické studii fáze III pro léčbu makulární degenerace související s věkem ve vlhkém stavu. Vyvíjí se také RGX- 121, který je v klinické studii fáze I/II k léčbě mukopolysacharidózy typu II; RGX- 111, který je v klinické studii fáze I/II k léčbě mukopolysacharidózy typu I; RGX- 181, který je v předklinickém stádiu k léčbě pozdní infantilní neuronální celotěrové lipofuscinózy typu II; RGX- 202 k léčbě Duchenneovy svalové dystrofie, která je v klinické studii fáze I/II; a RGX GX- 381, k léčbě očních projevů onemocnění CLN2, které je v předklinickém stádiu. Společnost REGENXBIO Inc. rovněž poskytuje licence na svou technologickou platformu NAV jiným biotechnologickým a farmaceutickým společnostem a má smlouvu o spolupráci a licenci se společností Neurimmune AG na vývoj nových genových terapií. Společnost REGENXBIO Inc. byla založena v roce 2008 a sídlí v Rockville v Marylandu.
Sektor
Healthcare
Odvětví
Biotechnology
Počet zaměstnanců
353
Založení
2015-09-17
Adresa
9804 Medical Center Drive
CEO
Curran M. Simpson

Zahraniční články

Výsledovka

Rozvaha

Peněžní toky

Výsledovka

Výsledovka
Rozvaha
Peněžní toky
V miliónech (USD)
Revenue TTM 2025202420232022202120202019201820172016201520142013
Total Revenues170.4170.483.390.2112.7470.3154.635.2218.510.44.67.66.16.1
Cost of Revenues80.320.333.637.254.551.835.78.29.61.71.01.51.00.3
Gross Profit90.1150.149.853.058.2418.5118.927.0208.98.73.66.15.15.8
Revenue 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Total Revenues30.329.721.489.021.224.222.315.622.228.9
Cost of Revenues5.961.89.13.46.312.414.68.515.612.4
Gross Profit24.4-32.112.285.614.911.87.77.26.616.5
Operating Income TTM 2025202420232022202120202019201820172016201520142013
R&D Expenses0.00.00.0232.3242.5181.4166.3124.283.957.245.517.35.05.1
Selling General & Admin Expenses0.00.00.088.585.379.363.851.836.927.223.611.93.95.5
Depreciation & Amortization15.615.616.217.30.30.74.3-48.64.02.70.50.10.00.0
Total Operating Expenses251.3311.3283.1321.2321.1258.5238.1176.0120.884.669.029.28.810.5
Operating Income-161.2-161.2-233.3-268.1-262.9160.0-119.2-149.088.1-75.9-65.3-23.1-3.7-4.8
Operating Income TTM 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
R&D Expenses0.00.00.00.00.00.00.00.051.358.2
Selling General & Admin Expenses0.00.00.00.00.00.00.00.019.123.1
Depreciation & Amortization3.93.93.94.04.04.04.14.24.34.4
Total Operating Expenses82.020.375.573.466.373.963.768.970.581.5
Operating Income-57.6-52.4-63.312.1-51.4-62.1-56.0-61.8-63.9-65.0
Net Income TTM 2025202420232022202120202019201820172016201520142013
Interest Income6.212.30.20.00.30.74.33.08.90.00.00.00.00.0
Interest Expense45.045.012.76.923.326.30.80.00.00.00.00.00.30.6
Other Expense-32.7-32.76.24.5-17.5-18.713.251.57.12.71.90.30.00.0
IBT-193.9-193.9-227.1-263.6-280.4141.2-106.0-97.5104.1-73.2-63.4-22.8-4.0-5.4
Income Tax Expense0.00.00.0-0.2-0.113.45.2-2.84.20.7-0.4-0.10.30.6
Net Income-193.9-193.9-227.1-263.5-280.3127.8-111.3-94.799.9-73.2-63.0-22.8-4.0-5.4
Net Income TTM 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Interest Income2.80.03.40.00.10.00.00.02.40.1
Interest Expense12.313.211.08.69.40.80.42.01.41.6
Other Expense-9.5-9.5-7.6-6.00.22.53.0-1.60.93.1
IBT-67.1-61.9-70.96.1-51.2-59.6-53.0-63.3-63.0-61.9
Income Tax Expense0.00.00.00.00.00.00.00.0-0.2-2.7
Net Income-67.1-61.9-70.96.1-51.2-59.6-53.0-63.3-62.9-61.9
Per Share Data TTM 2025202420232022202120202019201820172016201520142013
EPS$0.00$0.00$0.00$-6.02$-6.50$3.01$-2.98$-2.58$2.99$-2.45$-2.38$-2.49$-0.30$-0.41
EPS Diluted$0.00$0.00$0.00$-6.02$-6.50$2.91$-2.98$-2.58$2.73$-2.45$-2.38$-2.49$-0.30$-0.41
Shares Outstanding51.851.649.543.743.242.437.336.733.429.926.49.213.113.1
Diluted Shares Outstanding51.851.649.543.743.243.937.336.736.629.926.49.213.113.1
Per Share Data TTM 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
EPS$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$-1.43$-1.41
EPS Diluted$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$-1.43$-1.41
Shares Outstanding51.851.751.551.450.950.850.645.744.043.9
Diluted Shares Outstanding51.851.751.551.450.950.850.645.744.043.9
Current Assets TTM 202420232022202120202019201820172016201520142013
Cash And Equivalents57.857.534.597.0345.2338.469.575.646.724.854.11.11.1
Short Term Investments232.6177.2240.7267.7112.2137.3226.7244.2114.164.760.00.00.0
Total Cash & ST Investments290.4234.7275.3364.6457.4475.7296.2319.8160.889.6114.11.11.1
Accounts Receivable24.221.626.328.132.443.038.18.60.51.02.11.91.1
Inventory0.00.00.013.918.810.56.55.75.31.81.00.00.0
Other Current Assets32.121.733.49.410.22.04.23.81.41.00.90.00.0
Total Current Assets346.7278.0335.0416.0518.8531.2345.0337.9168.093.4118.13.02.2
Current Assets 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Cash And Equivalents58.879.6130.157.556.657.8113.034.553.068.6
Short Term Investments215.4243.7137.8177.2198.8232.6225.7240.7248.8251.5
Total Cash & ST Investments274.2323.3267.9234.7255.5290.4338.7275.3301.9320.1
Accounts Receivable26.521.519.221.625.224.217.326.331.727.0
Inventory0.00.00.00.00.00.00.00.012.615.1
Other Current Assets31.329.026.221.732.832.139.433.433.935.3
Total Current Assets332.0373.8313.2278.0313.4346.7395.4335.0365.8378.8
Long-Term Assets TTM 202420232022202120202019201820172016201520142013
Net Property, Plant & Equipment180.3171.3192.6206.8192.5120.339.128.714.09.30.50.00.0
Goodwill0.00.00.00.00.00.00.00.00.00.00.00.00.0
Intangible Assets0.00.00.00.00.00.00.00.00.00.00.00.00.0
Long-Term Investments39.410.238.9200.6391.946.8103.8150.815.669.4102.50.30.3
Other Long-Term Assets2.96.57.59.910.79.910.026.41.10.60.20.20.0
Total Long-Term Assets222.7188.0239.0417.3595.1177.0152.9205.930.779.4103.20.50.3
Total Assets569.4466.0574.0833.31,113.9708.2497.9543.8198.7172.7221.43.52.5
Long-Term Assets 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Net Property, Plant & Equipment156.3161.5166.6171.3175.8180.3185.2192.6197.3201.1
Goodwill0.00.00.00.00.00.00.00.00.00.0
Intangible Assets0.00.00.00.00.00.00.00.00.00.0
Long-Term Investments32.640.34.910.223.139.444.441.662.695.3
Other Long-Term Assets4.35.56.26.56.82.94.24.88.07.2
Total Long-Term Assets193.2207.3177.7188.0205.7222.7233.8239.0267.9303.6
Total Assets525.2581.0490.9466.0519.1569.4629.2574.0633.8682.5
Current Liabilities TTM 202420232022202120202019201820172016201520142013
Accounts Payable16.422.822.827.211.410.66.44.44.81.51.00.30.3
Short-Term Debt39.47.914.16.01.82.52.40.00.00.00.02.40.0
Other Current Liabilities42.572.493.295.4114.067.921.517.29.68.13.26.34.4
Current Liabilities98.3103.2130.3130.4130.581.433.722.214.49.74.39.24.7
Current Liabilities 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Accounts Payable22.321.719.022.819.516.431.422.821.911.6
Short-Term Debt50.88.07.97.97.739.445.714.113.312.7
Other Current Liabilities38.375.966.272.475.342.533.193.291.893.2
Current Liabilities124.6119.5106.7103.2102.798.3110.2130.3127.3117.9
Long-Term Liabilities TTM 202420232022202120202019201820172016201520142013
Long-Term Debt41.174.182.288.884.970.28.95.90.00.00.00.00.0
Capital Leases78.282.089.394.886.772.711.35.90.00.00.00.00.0
Def. Tax Liability0.00.00.00.00.00.00.01.10.00.00.00.00.0
Total Liabilities221.1206.3262.2317.1349.6330.447.735.015.611.04.69.24.7
Long-Term Liabilities 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Long-Term Debt217.369.671.974.176.3119.3124.982.284.185.3
Capital Leases0.077.779.882.084.178.280.282.290.791.6
Def. Tax Liability0.00.00.00.00.00.00.00.00.00.0
Total Liabilities363.8367.3216.7206.3217.7221.1238.5262.2270.7276.6
Total Common Equity TTM 202420232022202120202019201820172016201520142013
Common Stock0.00.00.00.00.00.00.00.00.00.00.00.010.9
Retained Earnings-821.4-932.1-705.0-441.6-161.2-289.1-177.8-83.0-187.8-114.6-51.6-28.8-24.8
Comprehensive Income-2.3-0.7-4.4-15.4-2.6-0.40.2-0.7-0.70.0-0.70.00.0
Total Common Equity348.3259.7311.7516.2764.3377.8450.2508.8183.0161.7216.8-5.7-2.1
Total Common Equity 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Common Stock0.00.00.00.00.00.00.00.00.00.0
Retained Earnings-1,058.9-996.9-926.1-932.1-881.0-821.4-768.4-705.0-642.2-580.3
Comprehensive Income-0.7-0.8-0.8-0.7-0.6-2.3-3.2-4.4-7.4-10.1
Total Common Equity161.5213.7274.2259.7301.4348.3390.7311.7363.1405.9
Other TTM 202420232022202120202019201820172016201520142013
Total Debt158.782.089.394.886.772.711.35.90.00.00.02.40.0
Book Value348.3259.7311.7516.2764.3377.8450.2508.8183.0161.7216.8-5.7-2.1
Other 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Total Debt0.00.00.00.00.00.00.00.00.00.0
Book Value161.5213.7274.2259.7301.4348.3390.7311.7363.1405.9
Cash Flow From Operating Activities TTM 2025202420232022202120202019201820172016201520142013
Net Income-241.1-193.9-227.1-263.5-280.3127.8-111.3-94.799.9-73.2-63.0-22.8-4.0-5.4
Depreciation & Amortization16.915.616.217.312.99.68.47.24.02.70.50.10.00.0
Stock-Based Compensation37.634.638.540.340.838.831.926.916.610.67.02.90.30.0
Change Working Capital-3.611.85.5-10.914.040.214.2-5.3-7.80.95.2-3.01.12.7
Change In Accounts Receivable-0.9-7.79.73.94.814.1-9.9-8.6-16.80.61.1-1.3-0.80.0
Change In Accounts Payable4.9-2.3-0.3-2.818.8-2.33.91.5-0.22.60.20.60.00.3
Change In Inventories-24.30.00.00.00.029.317.92.45.3-2.22.8-2.51.74.9
Other Non-cash Items53.48.0-6.2-1.65.24.4-1.2-2.7-8.9-0.3-0.40.00.2-0.3
Cash from Operations-191.10.00.0-218.4-207.5218.9-54.1-107.7104.6-58.0-48.6-22.5-2.4-3.0
Cash Flow From Operating Activities 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Net Income-67.1-61.9-70.96.1-51.2-59.6-53.0-63.3-62.9-61.9
Depreciation & Amortization3.93.93.94.04.04.04.14.24.34.4
Stock-Based Compensation8.49.08.78.59.59.99.49.68.310.2
Change Working Capital-1.8-10.47.516.411.76.1-4.0-8.29.2-0.6
Change In Accounts Receivable-0.6-6.3-2.41.68.1-0.7-6.99.23.4-6.5
Change In Accounts Payable-1.90.72.5-3.73.03.1-14.98.51.210.1
Change In Inventories0.00.00.00.00.00.00.00.0-20.1-4.2
Other Non-cash Items4.43.51.4-1.4-5.7-0.9-2.02.312.70.8
Cash from Operations0.00.00.00.00.00.00.00.0-40.8-49.4
Cash Flow From Investing Activities TTM 2025202420232022202120202019201820172016201520142013
Capital Expenditure-3.6-2.4-2.4-10.0-30.7-84.2-26.9-11.7-13.3-7.2-8.1-0.50.00.0
Acquisitions-75.20.00.00.00.0-5.00.0-296.0-179.7-0.50.00.00.00.0
Investments-174.5-332.6-190.1-86.6-184.9-498.1-123.0-190.7-445.8-68.6-45.1-163.30.00.0
Sales of Investment263.6319.1290.2287.5203.7175.7272.7296.0179.771.072.60.00.00.0
Other Investing Activities88.90.00.00.00.05.00.0296.0179.70.5-0.20.00.00.0
Cash from Investing85.50.00.0190.9-11.9-406.6122.893.6-279.4-4.819.2-163.80.00.0
Cash Flow From Investing Activities 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Capital Expenditure-0.5-0.5-0.4-1.0-1.1-0.3-0.5-0.6-1.1-1.4
Acquisitions0.00.00.00.00.00.00.00.0-35.1-40.1
Investments-62.8-39.5-211.1-19.2-16.2-36.2-82.5-55.2-18.6-18.1
Sales of Investment100.982.371.164.957.686.882.768.953.758.2
Other Investing Activities0.00.00.00.00.00.00.00.035.140.1
Cash from Investing0.00.00.00.00.00.00.00.034.038.7
Cash Flow From Financing Activities TTM 2025202420232022202120202019201820172016201520142013
Debt Repaid0.00.00.00.00.00.00.00.00.00.00.00.00.00.0
Debt Issued67.182.0-7.3-5.58.114.061.45.45.90.00.0-2.42.40.0
Issuance of Common Stock138.60.00.06.72.8216.40.00.0189.782.0-0.126.00.00.0
Repurchase of Common Stock1.70.01.20.01.71.81.81.30.80.60.00.00.00.0
Dividends Paid0.00.00.00.00.00.00.00.00.00.00.00.00.00.0
Other Financing Activities-38.20.00.0-42.7-33.4-23.0198.47.113.92.00.2213.32.42.0
Cash from Financing94.50.00.0-35.0-28.8195.3200.28.4204.484.60.1239.32.42.0
Cash Flow From Financing Activities 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Debt Repaid0.00.00.00.00.00.00.00.00.00.0
Debt Issued268.1190.4-2.2-2.2-2.0-74.7-11.981.3-1.4-0.9
Issuance of Common Stock0.00.00.00.00.00.00.00.0-0.26.1
Repurchase of Common Stock0.00.00.00.30.00.00.00.00.00.0
Dividends Paid0.00.00.00.00.00.00.00.00.00.0
Other Financing Activities0.00.00.00.00.00.00.00.0-12.0-4.8
Cash from Financing0.00.00.00.00.00.00.00.0-12.0-4.8
Cash position TTM 2025202420232022202120202019201820172016201520142013
Net Change in Cash-10.8-23.123.0-62.4-248.37.5268.9-5.829.721.8-29.353.00.0-1.0
Closing Cash Balance57.836.559.636.699.0347.2339.870.876.646.724.854.11.11.1
Cash position 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Net Change in Cash-24.3-20.8-50.572.60.9-1.1-55.278.5-18.5-15.6
Closing Cash Balance36.558.881.6132.159.658.659.8115.034.555.3
Free Cash Flow TTM 2025202420232022202120202019201820172016201520142013
Free Cash Flow-194.7-126.4-175.6-228.4-238.2134.7-80.9-119.491.4-65.2-56.7-23.0-2.4-3.0
Real Free Cash Flow-232.3-160.9-214.0-268.6-279.095.9-112.9-146.374.7-75.8-63.7-26.0-2.7-3.0
Free Cash Flow 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Free Cash Flow-52.8-56.5-49.732.6-32.7-40.9-46.0-56.0-41.9-50.8
Real Free Cash Flow-61.2-65.4-58.424.1-42.2-50.8-55.4-65.6-50.2-61.1
Nacenění
Finance
Efektivita
Marže
Dividenda
Ostatní

Nacenění

Ukazatel Aktuální Historické Konkurence
P/E-2.2-4.4-1.4
P/S2.525.99.4
P/B2.62.85.2
P/FCF-2.6-139.4-1.5
Market cap$0.6$0.7
P/E (Price to Earnings Ratio) – Poměr ceny akcie k zisku za posledních 12 měsíců. Říká, kolik korun investor zaplatí za 1 korunu zisku. Např.: P/E = 15 znamená, že pokud akcie stojí 15 Kč, firma vydělala 1 Kč za poslední rok.

Finance

Ukazatel Aktuální Historické Srovnání
Debt to Assets51.1 %9.5 %0 %
Debt to Income-138.3 %-16.2 %0 %
Debt to Free cash flow-166.6 %-224.4 %0 %
Interest expense percentage-27.9 %-0.9 %44.7 %
Current ratio2.7 9.1 0

Efektivita

Ukazatel Aktuální Historické Srovnání
ROE-120.1 %-26.1 %0 %
ROA-36.9 %-20.3 %0 %
CapEx to Revenue1.9 %30.4 %0 %
RaD to Revenue0 %251 %0 %
ROEM482,835.7 328985.4

Marže

Ukazatel Aktuální Historické Srovnání
Gross margin50 %76.9 %68.7 %
Operating margin-96 %-301.3 %35.5 %
Net margin-110.3 %-288.2 %9.5 %

Dividenda

Ukazatel Aktuální Historické Srovnání
Dividend yield0 %0 %0 %
Dividend payout percentage0 %0 %0 %
Dividend yield (Dividendový výnos) ukazuje aktuální procentuální výnos z dividend vůči ceně akcie.

Ostatní

Ukazatel Aktuální Historické
Shares outstanding51.7 mil 35.9 mil
Employee count0.4 tis 0.3 tis

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Akciový screener
Kalendář zisků
Super investoři
Porovnání akcií
preloader